A Novel Prescription Digital Therapeutic Option for the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease
Open Access
- 1 October 2023
- journal article
- research article
- Published by Elsevier in Gastro Hep Advances
- Vol. 3 (1) , 9-16
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Change in Glycemic Control With Use of a Digital Therapeutic in Adults With Type 2 Diabetes: Cohort StudyJMIR Diabetes, 2018
- Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysisDiabetes Care, 2018
- Practical Dietary Recommendations for the Prevention and Management of Nonalcoholic Fatty Liver Disease in AdultsAdvances in Nutrition, 2018
- Treatment of NAFLD with diet, physical activity and exerciseJournal of Hepatology, 2017
- Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of diseaseHepatology, 2017
- Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trialsTherapeutic Advances in Gastroenterology, 2016
- Psychological Interventions for the Management of Glycemic and Psychological Outcomes of Type 2 Diabetes Mellitus in China: A Systematic Review and Meta-Analyses of Randomized Controlled TrialsFrontiers in Public Health, 2015
- Long-Term Adherence to Health Behavior ChangeAmerican Journal of Lifestyle Medicine, 2013
- Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosisNature Reviews Gastroenterology & Hepatology, 2013
- Nonalcoholic fatty liver disease: A manifestation of the metabolic syndromeCleveland Clinic Journal of Medicine, 2008